Ayala Pharmaceuticals Inc (ADXS): ADXS-HER2 study; when did this begin? I...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Ayala Pharmaceuticals Inc (ADXS)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

huskercatman123

Send PM Follow Ignore

Followers	5
Posts	528
Boards Moderated	0
Alias Born	07/16/2013

huskercatman123

Re: None

Sunday, 03/12/2017 9:46:15 AM

Sunday, March 12, 2017 9:46:15 AM

ADXS-HER2 study; when did this begin? I must have been asleep at the wheel, because I do not remember seeing a PR on this study?

From company website : ADXS-HER2 is being evaluated in a first-in-human Phase 1b dose-escalation clinical study for the treatment of patients with metastatic HER2-expressing solid tumors. The dose escalation portion of the study will investigate the safety and tolerability of ADXS-HER2 as a monotherapy in patients diagnosed with metastatic HER2-expressing solid tumors. Results from the study will be used to determine the future clinical development program of ADXS-HER2.

Link to trial

https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/view?cdrid=770124&version=HealthProfessional&protocolsearchid=6139663

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ADXS News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:13:01 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:30:45 PM
Form DEFM14C - Definitive information statement relating to merger or acquisition • Edgar (US Regulatory) • 03/05/2024 01:16:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:30:46 PM
Form PREM14C - Preliminary information statements relating to merger or acquisition • Edgar (US Regulatory) • 02/20/2024 10:22:48 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:26:22 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 07:16:21 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 04:58:05 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 01:27:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 10:15:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:51:21 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/03/2024 09:18:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 02:04:41 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/21/2023 02:00:50 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 02:00:30 PM

More ADXS News

InvestorsHub NewsWire

Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM

HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM

Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM

Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM

Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM

Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow